Phase 1 trials for two novel treatments of obesity and/or diabetes initiated by Zealand partner Boehringer Ingelheim
August 22, 2017 09:45 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 39/2017 ...
Completion of exercise in full of overallotment option of 15%
August 18, 2017 04:02 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No....
Overallotment option of 15% has been exercised
August 15, 2017 09:19 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 37/2017 ...
End of stabilization period
August 15, 2017 09:17 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 36/2017 End...
Completion of the initial public offering of American Depositary Shares and registration of capital increase
August 14, 2017 03:29 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 35/2017 ...
Zealand Pharma A/S publishes prospectus
August 10, 2017 08:07 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Zealand Pharma A/S publishes prospectus. ...
Zealand Pharma A/S publishes a prospectus regarding listing of 4,375,000 new shares on Nasdaq Copenhagen as part of its issue of American Depositary Shares listed on the Nasdaq in the US
August 10, 2017 08:02 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Zealand Pharma A/S...
Zealand Pharma A/S files final prospectus on a Form F-1 registration statement in connection with the initial public offering of American Depositary Shares in the United States
August 09, 2017 17:32 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Zealand Pharma A/S has today...
Stabilization period begins
August 09, 2017 10:12 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Zealand Pharma A/S has today received...
Zealand Pharma A/S prices its initial public offering of American Depositary Shares on The Nasdaq Global Select Market in the United States
August 08, 2017 20:14 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 31/2017 ...